EarlyCDT Lung is a simple blood test that detects the elevated presence of autoantibodies generated by the body’s immune system as a natural defence against cancer cells.
EarlyCDT was created by Oncimmune and Eastern AHSN is looking at supporting a project in primary care across parts of the region.
Find out more about EarlyCDT Lung
Impact review
There’s more information about EarlyCDT Lung and how we have supported Oncimmune in our latest impact review article on cancer.
Get in touch
To learn more about our projects to detect and treat cancer contact [email protected]
Visit the website
Find out more about EarlyCDT Lung and Oncimmune visit oncimmune.com